Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS INTL

Class A Ordinary Shares, nominal value $0.000273235 per share · CUSIP: G52694109

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RUBRIC CAPITAL MANAGEMENT LP

    Shares: 3,909,806.00 · Class: 9.24%

  • DAVID ROSEN

    Shares: 3,909,806.00 · Class: 9.24%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-066696
Form type
SCHEDULE 13G/A
Filer
Kiniksa Pharmaceuticals International, plc
CIK
CIK 1730430
Filed
Jul 09, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub